Figure 8From: Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeuticsSerum urate-lowering efficacy of febuxostat compared with placebo. Subjects with gout and baseline serum urate levels > 8.0 mg/dl received once daily doses of placebo or febuxostat for 28 days. Modified from [52].Back to article page